Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SPRY3 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | INO80D | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | NLRP9 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | CSF2RB | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | GATA1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | USP45 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | GPR171 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | RNASE2 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | ASAP2 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0002 |
mRNA | PRSS21 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |